Atlas Trials

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Clinical trial NCT06018558 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06018558
Sponsor
Ocugen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Geographic Atrophy
Start date
2023-02-23
Primary completion
2026-02-03
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.